This guide explores how carbon nanomaterials are breaking through the barriers in the way of commercially available multi-analyte biosensors.
As healthcare moves toward personalised, point-of-care testing, multi-analyte biosensors are becoming essential. But legacy materials like gold and CNTs can’t deliver the selectivity, sensitivity or scalability required. This guide explores how carbon nanomaterials are breaking through those barriers.
Engineered for biosensing, Gii combines high conductivity, anti-fouling properties and scalable manufacturing in a single 3D carbon nanomaterial. Download the guide to discover how Gii is making clinically viable, multi-analyte diagnostics a commercial reality.